Subunits of the vacuolar H plus -ATPase complex, Vma4 and Vma10, are essential for virulence and represent potential drug targets in Candida albicans
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Se Woong | - |
dc.contributor.author | Park, Young Kwang | - |
dc.contributor.author | Joo, Yoo Jin | - |
dc.contributor.author | Chun, Yu Jin | - |
dc.contributor.author | Hwang, Ju Yeon | - |
dc.contributor.author | Baek, Je-Hyun | - |
dc.contributor.author | Kim, Joon | - |
dc.date.accessioned | 2021-09-01T05:10:57Z | - |
dc.date.available | 2021-09-01T05:10:57Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2019-10 | - |
dc.identifier.issn | 1878-6146 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/62774 | - |
dc.description.abstract | Hyphal morphogenesis of Candida albicans is important for its pathogenesis. Here, we showed that the filamentous growth of C. albicans requires vacuolar H+-ATPase function. Results showed that levels of Vma4 and Vma10 increased in cells undergoing hyphal growth compared to those undergoing yeast growth. Deleting VMA4 or VMA10 abolished vacuolar functions and hyphal morphogenesis. These deletion mutants were also characterized as avirulent in a mouse model of systemic infection. Furthermore, VMA4 and VMA10 deletion strains showed hypersensitivity to fluconazole, terbinafine, and amphotericin B. Based on these findings, Vma4 and Vma10 are not only involved in vacuole biogenesis and hyphal formation, but also are good targets for antifungal drug development in C. albicans. (C) 2019 British Mycological Society. Published by Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCI LTD | - |
dc.subject | YEAST V-ATPASE | - |
dc.subject | GENE | - |
dc.subject | ACIDIFICATION | - |
dc.subject | DOMAIN | - |
dc.subject | INHIBITORS | - |
dc.subject | INFECTION | - |
dc.subject | TRANSPORT | - |
dc.subject | AUTOPHAGY | - |
dc.subject | MUTANTS | - |
dc.subject | AGENTS | - |
dc.title | Subunits of the vacuolar H plus -ATPase complex, Vma4 and Vma10, are essential for virulence and represent potential drug targets in Candida albicans | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Joon | - |
dc.identifier.doi | 10.1016/j.funbio.2019.06.002 | - |
dc.identifier.scopusid | 2-s2.0-85067455943 | - |
dc.identifier.wosid | 000490047300002 | - |
dc.identifier.bibliographicCitation | FUNGAL BIOLOGY, v.123, no.10, pp.709 - 722 | - |
dc.relation.isPartOf | FUNGAL BIOLOGY | - |
dc.citation.title | FUNGAL BIOLOGY | - |
dc.citation.volume | 123 | - |
dc.citation.number | 10 | - |
dc.citation.startPage | 709 | - |
dc.citation.endPage | 722 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Mycology | - |
dc.relation.journalWebOfScienceCategory | Mycology | - |
dc.subject.keywordPlus | YEAST V-ATPASE | - |
dc.subject.keywordPlus | GENE | - |
dc.subject.keywordPlus | ACIDIFICATION | - |
dc.subject.keywordPlus | DOMAIN | - |
dc.subject.keywordPlus | INHIBITORS | - |
dc.subject.keywordPlus | INFECTION | - |
dc.subject.keywordPlus | TRANSPORT | - |
dc.subject.keywordPlus | AUTOPHAGY | - |
dc.subject.keywordPlus | MUTANTS | - |
dc.subject.keywordPlus | AGENTS | - |
dc.subject.keywordAuthor | C. albicans | - |
dc.subject.keywordAuthor | Candida drug | - |
dc.subject.keywordAuthor | Morphogenesis | - |
dc.subject.keywordAuthor | Pathogenesis | - |
dc.subject.keywordAuthor | V-ATPase | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.